Secondary hormonal therapies in the treatment of prostate cancer

This publication has 27 references indexed in Scilit:

• Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)
  Urology, 2001
• PC-SPES: current evidence and remaining questions.
  CA: A Cancer Journal for Clinicians, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• HERBAL THERAPY PC-SPES: IN VITRO EFFECTS AND EVALUATION OF ITS EFFICACY IN 69 PATIENTS WITH PROSTATE CANCER
  Journal of Urology, 2000
• A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma
  Cancer, 2000
• PC-SPES: A unique inhibitor of proliferation of prostate cancer cells in vitro and in vivo
  The Prostate, 2000
• Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer
  New England Journal of Medicine, 1998
• Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide Withdrawal
  Journal of Urology, 1997
• Induction of Apoptosis by Diethylstilbestrol in Hormone-Insensitive Prostate Cancer Cells
  JNCI Journal of the National Cancer Institute, 1996
• Prostate-specific antigen decline after casodex withdrawal: Evidence for an antiandrogen withdrawal syndrome
  Urology, 1994